n 0437, (-)-isomer has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, K; Hattori, N; Ikeda, J; Kondo, T; Mizuno, Y; Murata, M; Nomoto, M; Takeuchi, M; Tomida, T | 1 |
| Miranda C, M | 1 |
| Asgharnejad, M; Bauer, L; Dohin, E; Giladi, N; Nicholas, AP; Poewe, W; Woltering, F | 1 |
2 trial(s) available for n 0437, (-)-isomer and Disease Exacerbation
| Article | Year |
|---|---|
Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial.
Topics: Administration, Cutaneous; Age Factors; Aged; Antiparkinson Agents; Disease Progression; Double-Blind Method; Endpoint Determination; Female; Humans; Male; Middle Aged; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes | 2013 |
Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.
Topics: Aged; Disease Progression; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes | 2016 |
1 other study(ies) available for n 0437, (-)-isomer and Disease Exacerbation
| Article | Year |
|---|---|
[Transdermal Rotigotine in the treatment of restless legs patients who develop augmentation of symptoms].
Topics: Administration, Cutaneous; Aged; Disease Progression; Dopamine Agonists; Female; Humans; Male; Middle Aged; Restless Legs Syndrome; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes | 2013 |